Phase I Study of an AKT Inhibitor (MK-2206) Combined with Lapatinib in Adult Solid Tumors Followed by Dose Expansion in Advanced HER2+ Breast Cancer (Q36963374)
Jump to navigation
Jump to search
scientific article published on 29 March 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I Study of an AKT Inhibitor (MK-2206) Combined with Lapatinib in Adult Solid Tumors Followed by Dose Expansion in Advanced HER2+ Breast Cancer |
scientific article published on 29 March 2016 |
Statements
1 reference
Phase I Study of an AKT Inhibitor (MK-2206) Combined with Lapatinib in Adult Solid Tumors Followed by Dose Expansion in Advanced HER2+ Breast Cancer (English)
1 reference
Kari B Wisinski
1 reference
Amye J Tevaarwerk
1 reference
Mark E Burkard
1 reference
Murtuza Rampurwala
1 reference
Jens Eickhoff
1 reference
Maria C Bell
1 reference
Jill M Kolesar
1 reference
Christopher Flynn
1 reference
Glenn Liu
1 reference
29 March 2016
1 reference
1 reference
2659-2667
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference